Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to $75.9 million.

  • Strata Critical Medical's Cash & Current Investments fell 4431.63% to $75.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year decrease of 4431.63%. This contributed to the annual value of $124.8 million for FY2024, which is 2486.38% down from last year.
  • Latest data reveals that Strata Critical Medical reported Cash & Current Investments of $75.9 million as of Q3 2025, which was down 4431.63% from $113.4 million recorded in Q2 2025.
  • Strata Critical Medical's Cash & Current Investments' 5-year high stood at $333.2 million during Q2 2021, with a 5-year trough of $7.5 million in Q1 2021.
  • Over the past 5 years, Strata Critical Medical's median Cash & Current Investments value was $169.7 million (recorded in 2023), while the average stood at $178.7 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first soared by 3322699.03% in 2021, then tumbled by 4431.63% in 2025.
  • Strata Critical Medical's Cash & Current Investments (Quarter) stood at $282.0 million in 2021, then plummeted by 31.88% to $192.1 million in 2022, then decreased by 13.51% to $166.1 million in 2023, then decreased by 24.86% to $124.8 million in 2024, then tumbled by 39.18% to $75.9 million in 2025.
  • Its last three reported values are $75.9 million in Q3 2025, $113.4 million for Q2 2025, and $120.0 million during Q1 2025.